Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CymaBay Therapeutics, Inc.

http://www.cymabay.com

Latest From CymaBay Therapeutics, Inc.

Finance Watch: Two Biopharma IPOs Bring US Total To 17

Public Company Edition: Neumora grossed $250m and RayzeBio raised $311m in the first initial public offerings since early August. Also, ImmunityBio completes $470m in equity and debt financings, Bausch + Lomb sells $1.4bn worth of notes and Arbutus is among firms making cuts to conserve cash.

Financing Business Strategies

CymaBay’s Seladelpar Hits Three Endpoints In Phase III PBC Study

Seladelpar may threaten an entrenched second-line therapy, Intercept’s Ocaliva, with better efficacy, based on benefits demonstrated in the pivotal RESPONSE trial.

Business Strategies Clinical Trials

India Q2 2023 Deal Trends, What May Be In Store

India’s healthcare and life sciences segment saw deals worth over $3bn in Q2 2023 turbocharged by private equity activity in the hospitals space and smaller biopharma acquisitions. Watch the APIs and brands space for heightened M&A action, say experts.

Commercial Deals

Merck Life Execs On APAC Firms' mRNA Tech Readiness, Start-Ups And AI

Merck Life Science’s top executives in India tell Scrip how they are helping biologics companies in APAC on their mRNA therapy journey. In the wide-ranging discussion, use of AI, the startup environment for biotechs and the changing face of manufacturing in India also came up.

Commercial Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Metabolex, Inc.
    • Transplantation Technology, Inc.
    • Transtech Corporation
    • Transtech Medical, Inc.
UsernamePublicRestriction

Register